1,671
Views
1
CrossRef citations to date
0
Altmetric
Case Report

A case of an extreme white coat effect

, &
Pages 63-67 | Received 22 Jul 2019, Accepted 17 Aug 2019, Published online: 28 Aug 2019

References

  • Williams B, Mancia G, Spiering W, et al. 2018 ESC/ESH Guidelines for the management of arterial hypertension. Eur Heart J. 2018;1:3021–3104.
  • Dolan E, Stanton A, Atkins N, et al. Determinants of white-coat hypertension. Blood Press Monit. 2004;9:307–309.
  • Manios ED, Koroboki EA, Tsivgoulis GK, et al. Factors influencing white-coat effect. Am J Hypertens. 2008;21:153–158.
  • Grassi G, Turri C, Vailati S, et al. Muscle and skin sympathetic nerve traffic during the “white-coat” effect. Circulation. 1999;100:222–225.
  • Jhalani J, Goyal T, Clemow L, et al. Anxiety and outcome expectations predict the white-coat effect. Blood Press Monit. 2005;10:317–319.
  • Schutte AE, Huisman HW, van Rooyen JM, et al. Validation of the Finometer device for measurement of blood pressure in black women. J Hum Hypertens. 2004;18:79–84.
  • Kjeldsen SE, Lund-Johansen P, Nilsson PM, et al. Unattended blood pressure measurements in the systolic blood pressure intervention trial. Hypertension. 2016;67:808–812.
  • Fagard RH, Cornelissen VA. Incidence of cardiovascular events in white-coat, masked and sustained hypertension versus true normotension: a meta-analysis. J Hypertens. 2007;25:2193–2198.
  • Huang Y, Huang W, Mai W, et al. White-coat hypertension is a risk factor for cardiovascular diseases and total mortality. J Hypertens. 2017;35:677–688.
  • Franklin SS, Thijs L, Hansen TW, et al. Significance of white-coat hypertension in older persons with isolated systolic hypertension: a meta-analysis using the International Database on Ambulatory Blood Pressure Monitoring in Relation to Cardiovascular Outcomes population. Hypertension. 2012;59:564–571.
  • Whelton PK, Carey RM, Aronow WS, et al. ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American College of Cardiology/American Heart Association task force on clinical practice guidelines. J Am Coll Cardiol. 2018;71:e127–e248.
  • Kikuya M, Ohkubo T, Metoki H, et al. Day-by-day variability of blood pressure and heart rate at home as a novel predictor of prognosis: the Ohasama study. Hypertension. 2008;52:1045–1050.
  • Stevens SL, Wood S, Koshiaris C, et al. Blood pressure variability and cardiovascular disease: systematic review and meta-analysis. BMJ. 2016;356:i4098
  • Rothwell PM, Howard SC, Dolan E, et al. Prognostic significance of visit-to-visit variability, maximum systolic blood pressure, and episodic hypertension. Lancet. 2010;13:895–905.
  • Roest AM, Martens E, de Jonge P, et al. Anxiety and risk of incident coronary heart disease: a meta-analysis. J Am Coll Cardiol. 2010;29:38–46.
  • Portegies ML, Bos MJ, Koudstaal PJ, et al. Anxiety and the risk of stroke: the Rotterdam study. Stroke. 2016;47:1120–1123.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.